Dr. Einhorn shares if a woman with type 1 diabetes should join clinical trials.
Since type 1 diabetes is an autoimmune disease, ways to modulate your body’s immune system may change the course of illness, may soften the illness. There’s a number of strategies to modulate different lymphocytes. The immune system has many, many different layers, many ways to get at you. So there’s multiple approaches that are being tried and one of which may prove to be very successful and there are a number of clinical trials today.
If you were diagnosed new with type 1 diabetes, you should look to get into a clinical trial. So you go to the academic center or the endocrinologist in your community and see if you get into a clinical trial.
About Dr. Einhorn:
Dr. Daniel Einhorn received his undergraduate degree from Yale University, his medical degree from Tufts University School of Medicine, and his internship, residency and fellowship at Harvard Medical School. He served on the faculty of Harvard until coming to San Diego in 1984, and has since been a clinical endocrinologist with Diabetes and Endocrine Associates, Associate Clinical Professor of Medicine (Voluntary) at University of California, San Diego, and, until 2000, the Medical Director of the Diabetes Treatment and Research Center at Sharp Healthcare. He is the Medical Director of the Scripps Whittier Institute Diabetes Program. Dr. Einhorn has held many leadership positions with the Board of the American Association of Clinical Endocrinologists, the American Medical Association's Diabetes Advisory Council and The Endocrine Society. He Chaired the American College of Endocrinology Task Force on the Insulin Resistance Syndrome and the Conference on the Insulin Resistance Syndrome. He has served on the American Diabetes Association (ADA) Managed Care Initiative and on the regional ADA and Juvenile Diabetes Foundation, and as Chair of the Diabetes and Pregnancy Program of San Diego and Imperial Counties. He is a fellow of the American College of Physicians and the American College of Endocrinology. His research and publications cover diabetes prevention and reversal, recognition and treatment of diabetic complications, new technologies, new pharmaceuticals, combination therapies, and clinical decision-making.
View Dr. Einhorn's Videos:
Visit Dr. Einhorn at the Whittier Institute for Diabetes: